Correction: Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial

Detalles Bibliográficos
Autores principales: Chevret, Sylvie, Bouadma, Lila, Dupuis, Claire, Burdet, Charles, Timsit, Jean‑Francois
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541350/
https://www.ncbi.nlm.nih.gov/pubmed/37773550
http://dx.doi.org/10.1186/s13613-023-01194-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541350/
https://www.ncbi.nlm.nih.gov/pubmed/37773550
http://dx.doi.org/10.1186/s13613-023-01194-x

Ejemplares similares